IDWeek Commentary | Dr. Hongzhou Lu: Can ” Online Celebrity Weight Loss Drugs” Also Be Used for HIV-Infected Individuals?

IDWeek Commentary | Dr. Hongzhou Lu: Can ” Online Celebrity Weight Loss Drugs” Also Be Used for HIV-Infected Individuals?

Experiencing weight gain due to medication" is a common concern for many people living with HIV (PLWH). Some antiretroviral therapy (ART) regimens are associated with weight gain and related metabolic complications. In the field of endocrinology, newer antidiabetic medications like glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been used for weight management and have gained popularity. So, are these new weight loss treatments suitable for PLWH experiencing ART-related weight gain? At the 2023 Infectious Diseases Week (IDWeek 2023), two studies on the use of GLP-1 RAs in PLWH and one study of weight control using protease inhibitor switching were presented. Dr. Hongzhou Lu from Shenzhen Third People's Hospital (The Second Hospital Affiliated with the School of Medicine, Southern University of Science and Technology) provides an introduction and commentary on these studies.
IDWeek Live interview: Clinical Trials in Fungal Diseases That May Change Your Practice

IDWeek Live interview: Clinical Trials in Fungal Diseases That May Change Your Practice

In a special session titled "Clinical Trials That May Change Your Practice" at the 2023 Infectious Diseases Week (IDWeek 2023), Dr. George R. Thompson III of University of California Davis Medical Center presented a fascinating report on "Clinical Trials in Fungal Diseases That May Change Your Practice". He also granted an interview with "Infectious Disease Frontline"(IDF) after the conference.